Trials / Unknown
UnknownNCT05571657
COVID-19 Booster Dose Reminder/Recall for Adolescents
Understanding and Addressing the Disparity in Vaccination Coverage Among U.S. Adolescents Living in Rural Versus Urban Areas
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 4,304 (actual)
- Sponsor
- Marshfield Clinic Research Foundation · Academic / Other
- Sex
- All
- Age
- 12 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
A single COVID-19 booster dose has been recommended in the United States for adolescents aged ≥12 years to enhance protection against SARS-CoV-2 infection. This study will assess the efficacy of a one-time reminder/recall for COVID-19 booster dose among eligible adolescents in a regional healthcare system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Reminder/Recall Sent Via Preferred Method of Communication | Parents of 12-17 year-old patients due for COVID-19 booster dose will receive a one-time vaccine reminder/recall via the parent's preferred method of communication (mailed letter, text message, email) |
Timeline
- Start date
- 2022-05-12
- Primary completion
- 2022-08-30
- Completion
- 2022-12-31
- First posted
- 2022-10-07
- Last updated
- 2022-10-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05571657. Inclusion in this directory is not an endorsement.